2seventy bio Inc. (TSVT)
2.54
0.05 (2.01%)
At close: Jan 30, 2025, 12:50 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -217.57M | -254.15M | -292.21M | -120.11M | -320.59M | -199.75M |
| Depreciation & Amortization | 10.29M | 11.53M | 16.35M | 13.19M | 12.59M | 13.35M |
| Stock-Based Compensation | 32.16M | 41.04M | 54.63M | 61.00M | 62.05M | 40.80M |
| Other Working Capital | 3.03M | -36.20M | 13.34M | -2.23M | 20.53M | -6.05M |
| Other Non-Cash Items | 5.66M | 317.00K | 869.00K | -6.39M | 2.86M | 3.21M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 2.60M | -35.87M | 13.33M | -15.47M | 35.14M | -3.82M |
| Operating Cash Flow | -166.86M | -237.13M | -207.03M | -67.79M | -207.96M | -146.22M |
| Capital Expenditures | -13.87M | -22.84M | -19.57M | -22.26M | -59.77M | -50.83M |
| Acquisitions | n/a | -34.54M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -265.17M | -145.91M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 322.90M | 180.45M | 34.99M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 34.54M | -33.00M | n/a | n/a | n/a |
| Investing Cash Flow | 43.86M | 11.70M | 15.41M | -22.26M | -59.77M | -50.83M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | -1.02M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 527.00K | 696.00K | 354.89M | 90.05M | 267.72M | 198.06M |
| Financial Cash Flow | 127.39M | 166.23M | 354.89M | 90.05M | 267.72M | 197.04M |
| Net Cash Flow | 4.39M | -59.21M | 163.27M | n/a | n/a | n/a |
| Free Cash Flow | -180.72M | -259.98M | -226.61M | -90.05M | -267.72M | -197.04M |